13G Filing: Ardsley Partners and Marrone Bio Innovations Inc (MBII)

Marrone Bio Innovations Inc (NASDAQ:MBII): Philip Hempleman’s Ardsley Partners filed an amended 13D.

You can check out Ardsley Partners’ latest holdings and filings here.

Please follow Ardsley Partners (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Ardsley Partners or update its stock holdings.

Philip Hempleman
Philip Hempleman
Ardsley Partners

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Ardsley Advisory Partners 0 3,681,580 0 3,681,580 3,681,580 11.74%
Philip J. Hempleman 0 3,681,580 0 3,681,580 3,681,580 11.74%
Ardsley Partners I 0 3,631,580 0 3,631,580 3,631,580 11.58%
Ardsley Partners Fund II 0 595,300 0 595,300 595,300 1.90%
Ardsley Partners Advanced Healthcare Fund 0 1,189,700 0 1,189,700 1,189,700 3.79%
Ardsley Partners Renewable Energy Fund 0 1,846,580 0 1,846,580 1,846,580 5.89%
Ardsley Duckdive Fund 0 50,000 0 50,000 50,000 0.16%
Philip Hempleman
Philip Hempleman
Ardsley Partners

Page 1 of 13 – SEC Filing


Washington, D.C. 20549


the Securities Exchange Act of 1934

Marrone Bio
Innovations, Inc.

(Name of Issuer)


Common Stock

(Title of Class
of Securities)



(CUSIP Number)


31, 2017

(Date of Event
Which Requires Filing of this Statement)


Check the appropriate box to designate
the rule pursuant to which this Schedule is filed:


x Rule
x Rule
o Rule


*The remainder
of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject
class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior
cover page.


The information
required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the Notes).  


who are to respond to the collection of information contained in this form are not required to respond unless the form displays
a currently valid OMB control number.

Follow Marrone Bio Innovations Inc (NASDAQ:MBII)